Changes in smoking status affect women more than men: results of the Lung Health Study - PubMed (original) (raw)
Clinical Trial
. 2003 Jun 1;157(11):973-9.
doi: 10.1093/aje/kwg083.
Affiliations
- PMID: 12777360
- DOI: 10.1093/aje/kwg083
Clinical Trial
Changes in smoking status affect women more than men: results of the Lung Health Study
John E Connett et al. Am J Epidemiol. 2003.
Abstract
Lung Health Study participants were smokers aged 35-60 years with mild lung function impairment who participated in a 5-year, 10-center (nine in the United States, one in Canada) clinical trial in 1986-1994. The authors compared the relation of randomized treatment assignments and of smoking history during the study with changes in lung function between men and women. Spirometry was performed annually, and 3,348 men and 1,998 women attended the follow-up clinic visit that included spirometry at year 5. This paper reports on an analysis of changes in lung function by gender, treatment group, and three smoking history categories: sustained quitters, intermittent quitters, and continuing smokers. Among participants who quit smoking in the first year, mean forced expiratory volume in 1 second (FEV(1)) expressed as a percentage of the predicted value of FEV(1 )given the person's age, height, gender, and race (FEV(1)%) increased more in women (3.7% of predicted) than in men (1.6% of predicted) (p < 0.001). Across the 5-year follow-up period, among sustained quitters, women gained more in FEV(1)% of predicted than did men. Methacholine reactivity was more strongly related to rates of decline in women than in men (p < 0.001). Therefore, among persons at risk for chronic obstructive pulmonary disease, smoking cessation has an even clearer advantage for women than it does for men.
Similar articles
- The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study.
Wise RA, Kanner RE, Lindgren P, Connett JE, Altose MD, Enright PL, Tashkin DP; Lung Health Study Research Group. Wise RA, et al. Chest. 2003 Aug;124(2):449-58. doi: 10.1378/chest.124.2.449. Chest. 2003. PMID: 12907528 Clinical Trial. - Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.
Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS, Tashkin DP; Lung Health Study Research Group. Scanlon PD, et al. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):381-90. doi: 10.1164/ajrccm.161.2.9901044. Am J Respir Crit Care Med. 2000. PMID: 10673175 Clinical Trial. - Effect of weight gain on pulmonary function after smoking cessation in the Lung Health Study.
Wise RA, Enright PL, Connett JE, Anthonisen NR, Kanner RE, Lindgren P, O'Hara P, Owens GR, Rand CS, Tashkin DP. Wise RA, et al. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):866-72. doi: 10.1164/ajrccm.157.3.9706076. Am J Respir Crit Care Med. 1998. PMID: 9517604 Clinical Trial. - Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.
Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al. Anthonisen NR, et al. JAMA. 1994 Nov 16;272(19):1497-505. JAMA. 1994. PMID: 7966841 Clinical Trial. - Concomitant use of ipratropium and tiotropium in chronic obstructive pulmonary disease.
Cole JM, Sheehan AH, Jordan JK. Cole JM, et al. Ann Pharmacother. 2012 Dec;46(12):1717-21. doi: 10.1345/aph.1R283. Epub 2012 Nov 20. Ann Pharmacother. 2012. PMID: 23170031 Review.
Cited by
- Sex-differences in COPD: from biological mechanisms to therapeutic considerations.
Milne KM, Mitchell RA, Ferguson ON, Hind AS, Guenette JA. Milne KM, et al. Front Med (Lausanne). 2024 Mar 20;11:1289259. doi: 10.3389/fmed.2024.1289259. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38572156 Free PMC article. Review. - Sex-Related Differences in Oxidative, Platelet, and Vascular Function in Chronic Users of Heat-not-Burn vs. Traditional Combustion Cigarettes.
Schirone L, Loffredo L, Carnevale R, Battaglia S, Marti R, Pizzolo S, Bartimoccia S, Nocella C, Cammisotto V, Saade W, Tanzilli A, Sciarretta S, Chimenti I, De Falco E, Cavarretta E, Picchio V, Peruzzi M, Marullo A, Miraldi F, Violi F, Morelli A, Biondi-Zoccai G, Frati G. Schirone L, et al. Antioxidants (Basel). 2022 Jun 24;11(7):1237. doi: 10.3390/antiox11071237. Antioxidants (Basel). 2022. PMID: 35883727 Free PMC article. - Prediction of COPD risk accounting for time-varying smoking exposures.
Chang JT, Meza R, Levy DT, Arenberg D, Jeon J. Chang JT, et al. PLoS One. 2021 Mar 10;16(3):e0248535. doi: 10.1371/journal.pone.0248535. eCollection 2021. PLoS One. 2021. PMID: 33690706 Free PMC article. Clinical Trial. - Clinical Characteristics of Chronic Obstructive Pulmonary Disease in Female Patients: Findings from a KOCOSS Cohort.
Choi JY, Kim SY, Lee JH, Park YB, Kim YH, Um SJ, Jung KS, Yoo KH, Park SJ, Yoon HK. Choi JY, et al. Int J Chron Obstruct Pulmon Dis. 2020 Sep 22;15:2217-2224. doi: 10.2147/COPD.S269579. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33061339 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical